ICER announces updates to timeline for review of therapies for multiple sclerosis

16 September 2016 - The ICER has updated the timeline of its review of disease-modifying therapies for patients with multiple sclerosis. ...

Read more →

ICER releases addendum to draft scoping document for MS review

18 July 2016 - The ICER has released an addendum to the draft scoping document on disease-modifying therapies for multiple sclerosis. ...

Read more →